About

Beth McBride DiLauri is Director, Portfolio Marketing for BD Medical – Pharmaceutical Systems. Her responsibilities include developing portfolio strategies and leading commercialisation of drug delivery solutions for biologics. Ms McBride DiLauri has dedicated her career at BD to developing and executing portfolio strategies that impact patient care based on deep market and customer insights in pharma/biotech, medical devices, diagnostics and healthcare IT. She spent the early part of her career focused on structuring strategic partnerships, equity investments and acquisitions within BD and at Transcend Therapeutics, an early-stage biotechnology company that went public in 1997.

Ms McBride DiLauri received an MBA from the Tuck School of Business at Dartmouth College (NH, US) and a bachelor’s degree in Psychology from Boston College (MA, US).

Contributions

WEARABLES

BD INNOVATION FOR SUBCUTANEOUS DELIVERY OF LARGE-VOLUME COMPLEX BIOLOGICS

Beth McBride DiLauri summarises the results of a clinical study on the BD Libertas™ Wearable Injector. The results position the device as a viable alternative to traditional intravenous administration.

More contributions

WEARABLES

THE CHANGING DRUG DELIVERY PARADIGM

Beth DiLauri sets out the fundamental case for the adoption of wearable injectors, outlines the specific barriers they overcome and describes how the design and development of the BD Libertas™ wearable injector platform make it an attractive proposal for pharma companies.